DrugPatentWatch Database Preview
Par Form Company Profile
What is the competitive landscape for PAR FORM, and what generic and branded alternatives to PAR FORM drugs are available?
PAR FORM has five approved drugs.
There is one tentative approval on PAR FORM drugs.
Summary for Par Form
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
| Patent Litigation for Par Form: | See patent lawsuits for Par Form |
Drugs and US Patents for Par Form
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Par Form | LABETALOL HYDROCHLORIDE | labetalol hydrochloride | TABLET;ORAL | 200908-003 | Jul 10, 2012 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Par Form | FLUOXETINE HYDROCHLORIDE | fluoxetine hydrochloride | TABLET;ORAL | 203836-001 | Aug 19, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Par Form | ZOLPIDEM TARTRATE | zolpidem tartrate | TABLET;SUBLINGUAL | 201509-001 | Aug 1, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Par Form | LABETALOL HYDROCHLORIDE | labetalol hydrochloride | TABLET;ORAL | 200908-001 | Jul 10, 2012 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
